Advance Program | ADA 82nd Scientific Sessions - 23

ADVANCE PROGRAM
11:30 a.m.-12:30 p.m.
* General Poster Sessions
* ePoster Theater Sessions
12:30 p.m.-1:45 p.m.
* Session Break (Take this opportunity
to visit the Exhibit and Poster Halls)
1:45 p.m.-3:45 p.m.
* Residual Risk beyond LDL
Lp(a)
Joseph L. Witztum, MD
Triglyceride-Rich Lipoproteins and Their
Remnants
Henry N. Ginsberg, MD
Dysfunctional HDL
Anand Rohatgi, MD, MSCS
Drug Treatment for Residual Risk
beyond Statins
Ronald B. Goldberg, MD
* Stigma in Diabetes Care-Evidence
and Solutions (With Richard R. Rubin
Award Lecture)
Richard R. Rubin Award Lecture
Alan M. Delamater, PhD, ABPP
Oh, Sugar! Diabetes Has an Image
Problem-What Now?
Jane Speight, MSc, PhD, CPsychol,
FBPsS
Experiences of Weight Stigma and
Diabetes Stigma among People with
Type 2 Diabetes
Rebecca Pearl, PhD
Engaging Health-Care Professionals in
Changing Their Language to Reduce
Type 1 and Type 2 Diabetes-Related
Stigma
Kevin Joiner, PhD, APRN, ANP-BC,
CDE
Diabetes Stigma in Youth and Adults
Who Have Type 1 Diabetes and Their
Families
Susan Guzman, PhD
* National Standards for DSMES-
Revised and New for 2022!
National Standards for Diabetes SelfManagement
Education & Support -
2022
Amy Hess Fischl, MS, RDN, LDN, BCADM,
CDCES
Michelle F. Magee, MD, MB, BCh,
LRCPSI
Questions and Discussion Period
* Diabetes Excellence-The Gold
Standard for Education Services
Recognition and Education
Specialist Certification
Certified Diabetes Care & Education
Specialist (CDCES) Certification
Program Overview
Sheryl Traficano, MBA, CAE
Becky Sulik, RDN, CDCES, LD
Questions and Discussion Period
* Weighing the Evidence-Should
Obesity Be the Primary Target of
Treatment in Type 2 Diabetes?
Pro-Obesity Should Be the Primary
Target of Treatment in Type 2 Diabetes
Ildiko Lingvay, MD, MPH, MSCS
Con-Glucose Control Should Be the
Primary Target of Treatment in Type 2
Diabetes
Jeffrey I. Mechanick, MD
Question and Discussion Period
* A Transformative Approach to the
Prevention and Control of Diabetes
in the U.S-The National Clinical
Care Commission 2022 Report to
Congress
Foundational Recommendations to
Address Diabetes
William H. Herman, MD, MPH
Population-Level Diabetes Prevention
and Control
Dean Schillinger, MD
Diabetes Prevention in Targeted
Populations
Treatment and Complications
M. Carol Greenlee, MD, FACE, FACP
Overarching Recommendations and
Conclusions
Paul R. Conlin, MD
* Diabetes Digital Command
Centers-Beam Me Up, Scottie
Introduction-Relevance of Digital
Approaches to Clinical Care
Arlene Bierman, MD, MS
Developing a Digital Command Center
Infrastructure- Establishing The
Federation
David Scheinker, PhD
Data Transfer from Personal Digital
Diabetes Devices-How Can It Be
Done and Where Should it Go?-
Diabetes Device Ecosystem
Juan Espinoza, MD
Integrating Remote Patient Monitoring
and Virtual Care Delivery in the
Ambulatory Setting
Laura Talavera, MSN, MPH
Disseminated Models of Virtual
Diabetes Care (Regional Models)
Ashby F. Walker, PhD
* NIDDK Early Career Investigator
Symposium-Novel Diabetes
Prevention and Treatment
Approaches in Underserved and
Diverse Populations and Settings
Welcome Remarks from the NIDDK
Director
Identifying and Reducing Disparities
in Outcomes Among Economically
Vulnerable and Minority Young Adults
with Type 1 Diabetes
Shivani Agarwal, MD, MPH
Targeting Social Needs and Food
Insecurity in the Care of Individuals with
Type 2 Diabetes
Seth A. Berkowitz, MD, MPH
Strategies to Improve Diabetes
Management and Care in Racial/
Ethnic Diverse Populations and Under
Resourced Communities
Stephanie L. Fitzpatrick, PhD
Tackling Environmental Social
Determinants of Health to Prevent and
Treat Type 2 Diabetes in Underserved
(urban/rural) populations and Among
Black Men
David C. Lee, MD, MS
Strategies for Technology Tailoring and
Adoption to Improve Diabetes SelfManagement
and Nutrition Outcomes
Among Low-Resourced Patients
Roundtable Discussion
HYBRID | NEW ORLEANS | JUNE 3-7, 2022 | #ADA2022
Speakers and presentation titles are subject to change.
23

Advance Program | ADA 82nd Scientific Sessions

Table of Contents for the Digital Edition of Advance Program | ADA 82nd Scientific Sessions

Advance Program | ADA 82nd Scientific Sessions - 1
Advance Program | ADA 82nd Scientific Sessions - 2
Advance Program | ADA 82nd Scientific Sessions - 3
Advance Program | ADA 82nd Scientific Sessions - 4
Advance Program | ADA 82nd Scientific Sessions - 5
Advance Program | ADA 82nd Scientific Sessions - 6
Advance Program | ADA 82nd Scientific Sessions - 7
Advance Program | ADA 82nd Scientific Sessions - 8
Advance Program | ADA 82nd Scientific Sessions - 9
Advance Program | ADA 82nd Scientific Sessions - 10
Advance Program | ADA 82nd Scientific Sessions - 11
Advance Program | ADA 82nd Scientific Sessions - 12
Advance Program | ADA 82nd Scientific Sessions - 13
Advance Program | ADA 82nd Scientific Sessions - 14
Advance Program | ADA 82nd Scientific Sessions - 15
Advance Program | ADA 82nd Scientific Sessions - 16
Advance Program | ADA 82nd Scientific Sessions - 17
Advance Program | ADA 82nd Scientific Sessions - 18
Advance Program | ADA 82nd Scientific Sessions - 19
Advance Program | ADA 82nd Scientific Sessions - 20
Advance Program | ADA 82nd Scientific Sessions - 21
Advance Program | ADA 82nd Scientific Sessions - 22
Advance Program | ADA 82nd Scientific Sessions - 23
Advance Program | ADA 82nd Scientific Sessions - 24
Advance Program | ADA 82nd Scientific Sessions - 25
Advance Program | ADA 82nd Scientific Sessions - 26
Advance Program | ADA 82nd Scientific Sessions - 27
Advance Program | ADA 82nd Scientific Sessions - 28
Advance Program | ADA 82nd Scientific Sessions - 29
Advance Program | ADA 82nd Scientific Sessions - 30
Advance Program | ADA 82nd Scientific Sessions - 31
Advance Program | ADA 82nd Scientific Sessions - 32
https://www.nxtbookmedia.com